Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Alzheimer’s Disease Drugs Aduhelm, Leqembi May Cause Brain Shrinkage: Study Aduhelm and Leqembi side effects may actually speed up brain atrophy, making Alzheimer’s disease and dementia problems worse, researchers warn. April 19, 2023 Martha Garcia Add Your Comments A controversial new type of Alzheimer’s drug could actually speed up the progression of dementia in some cases by causing brain shrinkage, according to the findings of a new study. Australian researchers warn that the drugs, Aduhelm and Leqembi, which belong to a subclass of anti-amyloid beta drugs, may cause accelerated dementia in mildly cognitively impaired individuals. Their findings were published last month in the medical journal Neurology. Aduhelm (aducanumab) became the first novel therapy introduced for the treatment of Alzheimer’s since 2003, after it was granted approval through the FDA’s Accelerated Approval Program in June 2022. The drug is designed to reduce the presence of amyloid beta plaques in the brain, which are believed to be linked to the progression of the disease. However, the decision to approve Aduhelm immediately raised questions, since it was allowed on the market in the U.S. over the recommendations of an independent FDA advisory panel, which unanimously indicated the drug should not be approved due to questions about Aduhelm’s effectiveness treating Alzheimer’s. Leqembi (lecanemab), a similar drug, was just approved in January 2023. Potential Side Effects of Aduhelm and Leqembi The findings of this new study raise new signals about the potential side effects of Aduhelm and Leqembi, which are especially concerning given existing questions about the lack of benefits provided by the medications. Researchers from the University of Melbourne, Australia conducted a meta-analysis of clinical trials on this new class of dementia drugs. The report examined 31 clinical trials, looking for changes in the volume of the brain and investigating any Amyloid-Related Imaging Abnormalities (ARIA) detected during those trials. Two types of anti-amyloid beta drugs were compared; secretase inhibitors and ARIA-inducing monoclonal antibodies. Researchers found patients given the highest doses of these drugs appeared to experience accelerated volume changes to the whole brain, as well as the ventrical and hippocampus portions. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Anti-amyloid drugs are used to reduce amyloid plaques, which some research has linked with Alzheimer’s disease. But reducing amyloid plaque has not been proven to improve the disease, and many anti-amyloid drugs failed to improve the condition in clinical trials. According to the findings, secretase inhibitors accelerated brain atrophy to the hippocampus by 20% and to the entire brain by 22%. However, ARIA-inducing monoclonal antibodies, which include both Aduhelm and Leqembi, led to roughly 28% more brain shrinkage compared to control groups. Patients using those drugs also experienced a 39% increase in ventricular enlargement or the empty spaces of the brain. Researchers said the monoclonal drugs led to a level of brain shrinkage, and potential dementia progression, eight months earlier than if they didn’t receive treatment at all. However, they noted the shrinkage was not conclusively linked to the reduction of amyloid plaques. Critics propose the shrinkage may be linked to a reduction of inflammation in the brain and the clearing of antibodies. That theory is not proven, and brain shrinkage can be an indicator of neurodegeneration and brain damage. “These findings reveal the potential for anti-amyloid therapies to compromise long-term brain health by accelerating brain atrophy and provide new insight into the adverse impact of ARIA,” wrote study authors. Aduhelm Approval Controversy Scrutiny already surrounds Aduhelm after the FDA’s controversial approval of the drug, which came despite evidence from a clinical trial indicating the drug may not be able to slow Alzheimer’s disease. Aduhelm also failed two of the phase-3 clinical trials, which were ended early because the researchers failed to see improvements among patients. The FDA bucked the unanimous recommendation of its scientific advisory committee and approved the drug for use. Two members of the advisory committee resigned in protest and called the FDA’s move the “worst drug approval decision in recent U.S. history.” Later, after a congressional committee concluded the FDA approved the drug inappropriately and ignored agency protocol, the agency moved to approve the second Alzheimer’s drug, Leqembi. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Aduhelm, Alzheimer's Disease, Brain Injury, Cognition, Dementia, Leqembi Image Credit: | More Lawsuit Stories Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday September 26, 2025 Lawsuit Claims AngioDynamics BioFlo Port Catheters Defectively Designed September 26, 2025 RealPage Settlement Reached Over Rental Price Fixing Software September 26, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (Posted: yesterday) A federal judge will hear oral arguments on Monday over whether Depo-Provera lawsuit failure to warn claims are preempted by federal law. MORE ABOUT: DEPO-PROVERA LAWSUITLink Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (09/17/2025)Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025) Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (Posted: 2 days ago) Rideshare company Lfyt faces a sexual assault lawsuit from a Georgia woman who says a driver exposed himself after she ordered a ride home from a babysitting job. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITTwo Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)Uber Passenger Sexual Assault Trial Underway in California State Court (09/10/2025)Uber Sexual Assault Lawsuit Set To Go Before Jury in Jan. 2026 (09/04/2025) Exploding Isopropyl Bottles Make Smokeless Fire Pits Inherently Dangerous, Lawsuits Claim (Posted: 3 days ago) Lawsuits allege tabletop fire pits are inherently dangerous because they encourage consumers to fuel them with ordinary isopropyl bottles, which can explode in seconds and cause devastating burn injuries. MORE ABOUT: TABLETOP FIRE PIT LAWSUITTabletop Fire Pit Recall Announced by Five Below Amid Growing Number of Burn Injury Lawsuits (09/18/2025)Lawsuit Alleges Portable Fire Pit Sold on Amazon.com Caused Flashback Burn Injuries (09/12/2025)Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (09/05/2025)
Judge To Hear Depo-Provera Lawsuit Preemption Arguments on Monday (Posted: yesterday) A federal judge will hear oral arguments on Monday over whether Depo-Provera lawsuit failure to warn claims are preempted by federal law. MORE ABOUT: DEPO-PROVERA LAWSUITLink Between Depo-Provera and Meningioma Brain Tumors Ignored by Pfizer, Plaintiffs Indicate (09/22/2025)Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (09/17/2025)Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)
Lyft Sexual Assault Lawsuit Alleges Problems With Predatory Drivers Were Known for Years (Posted: 2 days ago) Rideshare company Lfyt faces a sexual assault lawsuit from a Georgia woman who says a driver exposed himself after she ordered a ride home from a babysitting job. MORE ABOUT: UBER SEXUAL ASSAULT LAWSUITTwo Uber Sexual Assault Bellwether Trials To Be Held in North Carolina (09/22/2025)Uber Passenger Sexual Assault Trial Underway in California State Court (09/10/2025)Uber Sexual Assault Lawsuit Set To Go Before Jury in Jan. 2026 (09/04/2025)
Exploding Isopropyl Bottles Make Smokeless Fire Pits Inherently Dangerous, Lawsuits Claim (Posted: 3 days ago) Lawsuits allege tabletop fire pits are inherently dangerous because they encourage consumers to fuel them with ordinary isopropyl bottles, which can explode in seconds and cause devastating burn injuries. MORE ABOUT: TABLETOP FIRE PIT LAWSUITTabletop Fire Pit Recall Announced by Five Below Amid Growing Number of Burn Injury Lawsuits (09/18/2025)Lawsuit Alleges Portable Fire Pit Sold on Amazon.com Caused Flashback Burn Injuries (09/12/2025)Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (09/05/2025)